PAVmed IncNASDAQ:PAVMNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
No Matches were found for
- LAST PRICE1.2561
- TODAY'S CHANGE (%)0.0061 (0.4880%)
- Bid / Lots1.2500/ 42
- Ask / Lots1.2600/ 2
- Open / Previous Close1.2799 / 1.2500
- Day Range
- 52 Week Range
- Volume3,561
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PAVM |
|---|---|---|
| 10:19 ET | 200 | 1.2799 |
| 10:26 ET | 100 | 1.28 |
| 10:33 ET | 700 | 1.26 |
| 10:37 ET | 150 | 1.255 |
| 10:39 ET | 392 | 1.25 |
| 10:55 ET | 733 | 1.2595 |
| 11:27 ET | 402 | 1.251 |
| 11:29 ET | 436 | 1.255 |
| 11:31 ET | 200 | 1.2561 |
Oct 1, 2024
Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players, from 8:01AM ET on Tuesday Oct 01, 2024 by Dow Jones
8:01AM ET on Tuesday Oct 01, 2024 by Dow Jones
Sep 24, 2024
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test, from 8:01AM ET on Tuesday Sep 24, 2024 by Dow Jones
8:01AM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 16, 2024
PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements, from 4:30PM ET on Monday Sep 16, 2024 by Dow Jones
4:30PM ET on Monday Sep 16, 2024 by Dow JonesPress Release: PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements, from 4:30PM ET on Monday Sep 16, 2024 by Dow Jones
4:30PM ET on Monday Sep 16, 2024 by Dow Jones
Sep 10, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
PAVmed Inc | 13.0M | -0.2x | --- |
BioElectronics Corp | 7.4M | -15.0x | --- |
ADM Tronics Unlimited Inc | 5.4M | -11.4x | --- |
Renalytix PLC | 18.7M | -0.2x | --- |
Longport Inc | 20.0 | 0.0x | --- |
Aksys Ltd | 30.0 | 0.0x | --- |
Company Information
No data available
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.0M |
|---|---|
Revenue (TTM) | $3.8M |
Shares Outstanding | 10.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-8.17 |
Book Value | $-6.28 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,704.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
